N/A
N=5
Connect for Caregivers
Social Isolation · Loneliness
Bottom Line
View on ClinicalTrials.gov: NCT04919070 ↗Enrolled (actual)
5
Serious AEs
0.0%
Results posted
Dec 2022
Primary outcome: Primary: Perceived Autonomy — 21.2 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Connect for Caregivers (Behavioral)
- Age
- Adult, Older Adult · 50+ yrs
- Sex
- All
- Sponsor
- University of Rochester
- Primary completion
- Aug 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Perceived Autonomy |
21.2 | — |
| PRIMARY Perceived Competence Scale |
16.4 | — |
| SECONDARY Knowledge of Social Engagement |
15.6 | — |
| SECONDARY Loneliness |
53.4 | — |
Summary
Connect for Caregivers is a intervention feasibility pilot study. The purpose of the study is to pilot test a newly developed single session behavioral intervention to help caregivers of individuals with Alzheimer's Disease or related dementias gain understanding of the importance of increasing social connectedness, awareness of their personal barriers to connectedness, and knowledge of local resources for promoting connectedness.
Eligibility Criteria
Inclusion Criteria
- Age ≥ 50 yrs;
- English speaking;
- Caregiver (age 50 or older) for a community-dwelling family member with ADRD, living with (or in close proximity to) family member with dementia;
- Elevated caregiving distress: Above population mean (>11) on 10-item Perceived Stress Scale (PSS-10) and/or at least moderate caregiver strain (score >= 5) on the Modified Caregiver Strain Index (MCSI).
- Social connectedness: UCLA Loneliness Scale: Short Form score of >5.
Exclusion Criteria
- Primary language is not English;
- Current problem drinking on the AUDIT-C (score of 5 or greater indicating exclusion);
- Current non-alcohol psychoactive substance abuse (MINI Neuropsychiatric Interview), psychotic disorders (current and lifetime, MINI), bipolar disorder (MINI), and current mood disorder with psychotic features (MINI);
- Significant cognitive impairment (MOCA <22); and
- Hearing problems that preclude completion of the intervention.
Data sourced from ClinicalTrials.gov (NCT04919070). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.